Analytical protocol for identification of BMAA and DAB in biological samples

Liquid Chromatographic Determination of the Cyanobacterial Toxin β-N-Methylamino-L-Alanine in Algae Food Supplements, Freshwater Fish, and Bottled Water

(2016) PETER M. SCOTT et al.   JOURNAL OF FOOD PROTECTION

Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease

(2009) J. Pablo et al.   ACTA NEUROLOGICA SCANDINAVICA

Beta-Methylamino-L-Alanine Analysis by Liquid Chromatography Tandem Mass Spectrometry with iTRAQ as the Derivative

(2009) Mark M. Kushnir et al.   EUROPEAN JOURNAL OF MASS SPECTROMETRY

Parkinson–dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue

(2009) Laura R. Snyder et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Improving derivatization efficiency of BMAA utilizing AccQ-Tag® in a complex cyanobacterial matrix

(2008) Johan Eriksson et al.   AMINO ACIDS

Determination of the neurotoxin BMAA (β-N-methylamino-l-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry)

(2008) Johan Rosén et al.   ANALYST

β-N-methylamino-l-alanine (BMAA) in novel South African cyanobacterial isolates

(2008) M. Esterhuizen et al.   ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

Effective determination method for a cyanobacterial neurotoxin, β-N-methylamino-l-alanine

(2008) Takuya Kubo et al.   TOXICON

1H NMR determination of β-N-methylamino-l-alanine (l-BMAA) in environmental and biological samples

(2008) Sidnei Moura et al.   TOXICON